Page last updated: 2024-08-25

atovaquone and Kidney Neoplasms

atovaquone has been researched along with Kidney Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, J; Chen, D; Sun, X; Zhang, X	1

Other Studies

1 other study(ies) available for atovaquone and Kidney Neoplasms

Article	Year
Targeting mitochondria by anthelmintic drug atovaquone sensitizes renal cell carcinoma to chemotherapy and immunotherapy. Journal of biochemical and molecular toxicology, 2018, Volume: 32, Issue:9 Topics: Animals; Anthelmintics; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Atovaquone; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Electron Transport Complex III; Enzyme Inhibitors; Humans; Interferon-alpha; Kidney Neoplasms; Male; Mice, SCID; Mitochondria; Oxidative Stress; Random Allocation; Tumor Burden; Xenograft Model Antitumor Assays	2018

Article

Year

Targeting mitochondria by anthelmintic drug atovaquone sensitizes renal cell carcinoma to chemotherapy and immunotherapy.

Journal of biochemical and molecular toxicology, 2018, Volume: 32, Issue:9

Topics: Animals; Anthelmintics; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Atovaquone; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Electron Transport Complex III; Enzyme Inhibitors; Humans; Interferon-alpha; Kidney Neoplasms; Male; Mice, SCID; Mitochondria; Oxidative Stress; Random Allocation; Tumor Burden; Xenograft Model Antitumor Assays

2018